Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Outcomes of tumor necrosis factor inhibitor cycling versus switching to a disease-modifying anti-rheumatic drug with a new mechanism of action among patients with rheumatoid arthritis
PaperCitations, authors & open-access status
Outcomes of tumor necrosis factor inhibitor cycling versus switching to a disease-modifying anti-rheumatic drug with a new mechanism of action among patients with rheumatoid arthritis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 37 citations, 2016 year and bronze oa status.
37
Citations
2016
Year
bronze
OA Status